Articles by GlobeNewswire

Technology

Brookfield Asset Management Announces Pricing of $600 Million Notes Due 2030 and $400 Million Notes Due 2036

Forward-Looking StatementsThis news release contains “forward-looking statements” within the meaning of the U.S. Securities Act of 1933, the U.S. Securities Exchange Act of 1934, “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of other relevant securities legislation, including applicable securities laws in Canada, which reflect our current views with respect to, among other things, our operations and financial performance (collectively, “forward-looking statements”). You can identify these forward-looking statements by the use of words such as “outlook”, “believe”, “think”, “expect”, “potential”, “continue”, “may”, “should”, “seek”, “approximately”, “predict”, “intend”, “will”, “plan”, “estimate”, “anticipate”, the negative version of these words, other comparable words or other statements that do not relate strictly to historical or factual matters. These statements identify prospective information. Important factors could cause actual results to differ, possibly materially, from those indicated in these statements. Forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. Such forward-looking statements are subject to risks and uncertainties and assumptions relating to our operations, financial results, financial condition, business prospects, growth strategy and liquidity. In particular, the forward-looking statements contained in this news release include statements referring to the offering, the expected use of proceeds from the offering and the expected closing date of the offering.

Nov 13, 2025

Business

DPM Metals Reports Record Third Quarter 2025 Financial Results; Vareš Positioned for Significant Value Creation

Article contentThe Company’s three-year outlook and 2025 detailed guidance do not reflect the operating and financial results of Vareš. DPM continues to expect minimal production at Vareš over the balance of 2025, consistent with the Vareš Technical Report entitled “Amended and Restated NI 43-101 Technical Report on the Vareš Mine, Bosnia and Herzegovina” dated June 9, 2025, available on SEDAR+ at www.sedarplus.ca and the Company’s website at www.dpmmetals.com. As the Vareš mine ramps up to achieving commercial production by the end of 2026, its 2026 production is now expected to be better than previously anticipated, with higher ore processed and higher gold and silver grades, as compared to the Vareš Technical Report.Article contentIn February 2026, DPM expects to provide a three-year outlook for the Vareš operation along with its corporate guidance.Article contentSelected Production, Delivery and Cost Performance, excluding Vareš, versus 2025 GuidanceArticle content Q3 2025YTD September 20252025 Consolidated Guidance ChelopechAda TepeConsolidatedChelopechAda TepeConsolidatedOre processedKt557.5223.4780.91,631.4560.62,192.02,700 – 2,900Metals contained in concentrates produced GoldKoz44.319.463.7128.746.0174.7225 – 265CopperMlbs7.8–7.820.1–20.128 – 33Payable metals in concentrates sold GoldKoz39.618.357.9110.445.2155.6205 – 240CopperMlbs6.8–6.817.2–17.225 – 29All-in sustaining cost per ounce of gold sold$/oz6711,0301,1686751,1591,136780 – 900 Article contentArticle contentFor additional information regarding the Company’s detailed guidance for 2025 and current three-year outlook, please refer to the “Three-Year Outlook” section of the MD&A.Article contentThird Quarter 2025 Results Conference Call and WebcastArticle contentAt 9 a.m. EDT on Friday, November 14, 2025, DPM will host a conference call and audio webcast to discuss the results, followed by a question-and-answer session. To participate via conference call, register in advance at the link provided below to receive the dial-in information as well as a unique PIN code to access the call.Article contentThe call registration and webcast details are as follows:Article contentConference call date and time Friday, November 14, 2025 9 a.m. EDTCall registration https://register-conf.media-server.com/register/BI3375ddab03dd45f79772f809863771edWebcast link https://edge.media-server.com/mmc/p/qxtpx66fReplay Archive will be available on www.dpmmetals.com Article contentThis news release and DPM’s unaudited condensed interim financial statements and MD&A for the three and nine months ended September 30, 2025 are posted on the Company’s website at www.dpmmetals.com and have been filed on SEDAR+ at www.sedarplus.ca.Article contentQualified PersonArticle contentThe technical and scientific information in this news release has been prepared in accordance with Canadian regulatory requirements set out in National Instrument 43-101 Standards of Disclosure for Mineral Projects (“NI 43-101”) of the Canadian Securities Administrators and the Canadian Institute of Mining, Metallurgy and Petroleum Definition Standards for Mineral Resources and Mineral Reserves, and has been reviewed and approved by Ross Overall, B.Sc. (Applied Geology), Director, Corporate Technical Services, of DPM, who is a Qualified Person as defined under NI 43-101, and who is not independent of the Company.Article contentAbout DPM Metals Inc.Article contentDPM Metals Inc. is a Canadian-based international gold mining company with operations and projects located in Bulgaria, Bosnia and Herzegovina, Serbia and Ecuador. The Company’s purpose is to unlock resources and generate value to thrive and grow together. Our strategic objective is to become a mid-tier precious metals company, which is based on sustainable, responsible and efficient gold production from our portfolio, the development of quality assets, and maintaining a strong financial position to support growth in mineral reserves and production through disciplined strategic transactions. This strategy creates a platform for robust growth to deliver above-average returns for our shareholders. DPM trades on the Toronto Stock Exchange (symbol: DPM) and Australian Securities Exchange as a Foreign Exempt Listing (symbol: DPM).Article contentFor further information, please contact:Article contentJennifer CameronDirector, Investor RelationsTel: (416) 219-6177jcameron@dpmmetals.comArticle contentCautionary Note Regarding Forward Looking StatementsArticle contentThis news release contains “forward looking statements” or “forward looking information” (collectively, “Forward Looking Statements”) that involve a number of risks and uncertainties. Forward Looking Statements are statements that are not historical facts and are generally, but not always, identified by the use of forward looking terminology such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “guidance”, “outlook”, “intends”, “anticipates”, “believes”, or variations of such words and phrases or that state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms or similar expressions. The Forward Looking Statements in this news release relate to, among other things: forecasted results of production in 2025 and the ability of the Company to meet previously provided guidance in respect thereof; expected cash flows; the price of gold, copper, and silver, and other minerals; estimated capital costs, all-in sustaining costs, operating costs and other financial metrics, including those set out in the outlook and guidance provided by the Company; the integration of the Vareš operation into the Company’s portfolio of assets, next steps in the integration process and the anticipating timing and costs thereof; expectations regarding production from the Vareš operation and the anticipated timing thereof; next steps in the development of the Vareš operation; currency fluctuations; results of economic studies; the intention to complete the FS in respect of the Čoka Rakita project and the anticipated timing thereof; anticipated steps in the continued development of the Čoka Rakita project, including exploration, permitting activities, environmental assessments, and stakeholder engagement, and the timing for completion and anticipated results thereof; exploration activities at the Company’s operating and development properties, including the Rakita Camp, and the anticipated results thereof; the completion of initial Inferred Mineral Resource estimates in respect of the Dumitru Potok, Rakita North, and Frasen prospects in Serbia and the anticipated timing thereof; next steps in the development of the Loma Larga project; actions which may be taken by the Company following the revocation of the environmental license for the Loma Larga project; anticipated amounts of expenditures that may be incurred in connection with the Loma Larga project; permitting requirements, the ability of the Company to obtain such permits, and the anticipated timing thereof; anticipated amounts of future expenditures at the Company’s operating and development properties, including expenses related to exploration activities; statements under the heading “2025 Guidance and Three-year Outlook”; timing of payments and amounts of dividends; and the number of common shares of the Company that may be purchased under the NCIB.Article contentForward Looking Statements are based on certain key assumptions and the opinions and estimates of management and Qualified Person (in the case of technical and scientific information), as of the date such statements are made, and they involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any other future results, performance or achievements expressed or implied by the Forward Looking Statements. In addition to factors already discussed in this news release, such factors include, among others: fluctuations in metal prices and foreign exchange rates; risks arising from the current economic environment and the impact on operating costs and other financial metrics, including risks of recession; the ability of the Company to successfully integrate the Vareš operation into the Company’s portfolio of assets; the ability of the Company to realize the anticipated benefits of the acquisition of the Vareš operation; the commencement, continuation or escalation of geopolitical crises and armed conflicts, including without limitation, in Ukraine, the Middle East, Ecuador, and other jurisdictions from time to time, and their direct and indirect effects on the operations of DPM; risks arising from counterparties being unable to or unwilling to fulfill their contractual obligations to the Company; the speculative nature of mineral exploration, development and production, including changes in mineral production performance, exploitation and exploration results; the Company’s dependence on its operations at the Chelopech mine and Ada Tepe mine; changes in tax and tariff regimes in the jurisdictions in which the Company operate or which are otherwise applicable to the Company’s business, operations, or financial condition; possible inaccurate estimates relating to future production, operating costs and other costs for operations; possible variations in ore grade and recovery rates; inherent uncertainties in respect of conclusions of economic evaluations, economic studies and mine plans; uncertainties with respect to the timing of completion and publication of technical studies of the Company’s exploration and development projects, including the Čoka Rakita project and Rakita Camp, and the results thereof; the Company’s dependence on continually developing, replacing and expanding its mineral reserves; uncertainties and risks inherent to developing and commissioning new mines into production, which may be subject to unforeseen delays; risks related to the possibility that future exploration results will not be consistent with the Company’s expectations, that quantities or grades of reserves will be diminished, and that resources may not be converted to reserves; risks associated with the fact that certain of the Company’s initiatives are still in the early stages and may not materialize; risks related to the Company’s ability to develop the Loma Larga project and to obtain necessary permits in respect thereof; changes in project parameters, including schedule and budget, as plans continue to be refined; risks related to the financial results of operations, changes in interest rates, and the Company’s ability to finance its operations; the impact of global liquidity and credit availability on the timing of cash flows and the values of assets and liabilities based on projected future cash flows; uncertainties inherent with conducting business in foreign jurisdictions where corruption, civil unrest, political instability and uncertainties with the rule of law may impact the Company’s activities; accidents, labour disputes and other risks inherent to the mining industry; failure to achieve certain cost savings; risks related to the Company’s ability to manage environmental and social matters, including risks and obligations related to closure of the Company’s mining properties; risks related to climate change, including extreme weather events, resource shortages, emerging policies and increased regulations relating to related to greenhouse gas emission levels, energy efficiency and reporting of risks; land reclamation and mine closure requirements, and costs associated therewith; the Company’s controls over financial reporting and obligations as a public company; delays in obtaining governmental approvals or financing or in the completion of development or construction activities; opposition by social and non-governmental organizations to mining projects; uncertainties with respect to realizing the anticipated benefits from the development of the Company’s exploration and development projects; cyber-attacks and other cybersecurity risks; competition in the mining industry; exercising judgment when undertaking impairment assessments; claims or litigation; limitations on insurance coverage; changes in values of the Company’s investment portfolio; changes in laws and regulations, including with respect to taxes, and the Company’s ability to successfully obtain all necessary permits and other approvals required to conduct its operations; employee relations, including unionized and non-union employees, and the Company’s ability to retain key personnel and attract other highly skilled employees; ability to successfully integrate acquisitions or complete divestitures; unanticipated title disputes; volatility in the price of the common shares of the Company; potential dilution to the common shares of the Company; damage to the Company’s reputation due to the actual or perceived occurrence of any number of events, including negative publicity with respect to the Company’s handling of environmental matters or dealings with community groups, whether true or not; risks related to holding assets in foreign jurisdictions; conflicts of interest between the Company and its directors and officers; the timing and amounts of dividends; there being no assurance that the Company will purchase additional common shares of the Company under the NCIB, as well as those risk factors discussed or referred to in the MD&A, the Company’s most recent AIF, the Company’s management information circular dated July 11, 2024, and other documents filed from time to time with the securities regulatory authorities in all provinces and territories of Canada and available on SEDAR+ at www.sedarplus.ca.Article contentThe reader has been cautioned that the foregoing list is not exhaustive of all factors and assumptions which may have been used. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in Forward Looking Statements, there may be other factors that cause actions, events or results not to be anticipated, estimated or intended. There can be no assurance that Forward Looking Statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company’s Forward Looking Statements reflect current expectations regarding future events and speak only as of the date hereof. Other than as it may be required by law, the Company undertakes no obligation to update Forward Looking Statements if circumstances or management’s estimates or opinions should change. Accordingly, readers are cautioned not to place undue reliance on Forward Looking Statements.Article contentNon-GAAP Financial MeasuresArticle contentCertain financial measures referred to in this news release are not measures recognized under IFRS and are referred to as non-GAAP financial measures or ratios. These measures have no standardized meanings under IFRS and may not be comparable to similar measures presented by other companies. The definitions established and calculations performed by DPM are based on management’s reasonable judgment and are consistently applied. These measures are used by management and investors to assist with assessing the Company’s performance, including its ability to generate sufficient cash flow to meet its return objectives and support its investing activities and debt service obligations. In addition, the Human Capital and Compensation Committee of the Board of Directors uses certain of these measures, together with other measures, to set incentive compensation goals and assess performance. These measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures prepared in accordance with IFRS. Non-GAAP financial measures and ratios, together with other financial measures calculated in accordance with IFRS, are considered to be important factors that assist investors in assessing the Company’s performance.Article contentCash cost and all-in sustaining cost measures Article contentMine cash cost; mine cash cost of sales; and all-in sustaining cost are non-GAAP financial measures. Cash cost per tonne of ore processed; cash cost per ounce of gold sold; and all-in sustaining cost per ounce of gold sold are non-GAAP ratios. These measures capture the important components of the Company’s production and related costs. Management and investors utilize these metrics as an important tool to monitor cost performance at the Company’s operations. In addition, the Human Capital and Compensation Committee of the Board of Directors uses certain of these measures, together with other measures, to set incentive compensation goals and assess performance.Article contentThe following table provides a reconciliation of the Company’s cash cost per tonne of ore processed to its cost of sales, excluding Vareš:Article content$ thousands Three Months Nine Monthsunless otherwise indicated 2025 2024 2025 2024 Chelopech Ore processedt557,497 512,836 1,631,444 1,592,986 Cost of sales 44,798 40,311 122,842 114,054 Add/(deduct): Depreciation and amortization (8,945)(8,088) (25,393)(23,742)Change in concentrate inventory (603)(1,019) 53 491 Mine cash cost(1) 35,250 31,204 97,502 90,803 Cost of sales per tonne of ore processed(2)$/t80 79 75 72 Cash cost per tonne of ore processed(2)$/t63 61 60 57 Ada Tepe Ore processedt223,427 198,254 560,602 574,845 Cost of sales 32,192 27,000 83,858 80,722 Deduct: Depreciation and amortization (17,620)(12,882) (43,452)(40,933)Change in concentrate inventory (13)(74) (45)(78)Mine cash cost(1) 14,559 14,044 40,361 39,711 Cost of sales per tonne of ore processed(2)$/t144 136 150 140 Cash cost per tonne of ore processed(2)$/t65 71 72 69 Article content(1) Cash costs are reported in U.S. dollars, although the majority of costs incurred are denominated in non-U.S. dollars, and consist of all production related expenses including mining, processing, services, royalties and general and administrative.(2) Represents cost of sales and mine cash cost, respectively, divided by tonnes of ore processed.Article contentThe following tables provide, for the periods indicated, a reconciliation of the Company’s cash cost per ounce of gold sold and all-in sustaining cost per ounce of gold sold to its cost of sales, excluding Vareš:Article content$ thousands, unless otherwise indicated For the three months ended September 30, 2025 Chelopech Ada Tepe Consolidated,excluding Vareš Cost of sales(1) 44,798 32,192 76,990 Add/(deduct): Depreciation and amortization (8,945)(17,620)(26,565)Treatment charges, transportation and other related selling costs(2) 18,288 (26)18,262 By-product credits(3) (33,001)(368)(33,369)Mine cash cost of sales 21,140 14,178 35,318 Rehabilitation related accretion and depreciation expenses(4) 22 1,245 1,267 Allocated general and administrative expenses(5) – – 22,227 Cash outlays for sustaining capital expenditures(6) 4,968 3,189 8,157 Cash outlays for leases(6) 448 219 667 All-in sustaining cost 26,578 18,831 67,636 Payable gold in concentrates soldoz39,627 18,285 57,912 Cost of sales per ounce of gold sold(7)$/oz1,130 1,761 1,329 Cash cost per ounce of gold sold(7)$/oz533 775 610 All-in sustaining cost per ounce of gold sold(7)$/oz671 1,030 1,168 Article content$ thousands, unless otherwise indicated For the three months ended September 30, 2024 Chelopech Ada Tepe Consolidated,excluding Vareš Cost of sales(1) 40,311 27,000 67,311 Add/(deduct): Depreciation and amortization (8,088)(12,882)(20,970)Treatment charges, transportation and other related selling costs(2) 16,476 621 17,097 By-product credits(3) (28,549)(196)(28,745)Mine cash cost of sales 20,150 14,543 34,693 Rehabilitation related accretion expenses(4) 10 297 307 Allocated general and administrative expenses(5) – – 11,295 Cash outlays for sustaining capital expenditures(6) 3,435 3,103 6,538 Cash outlays for leases(6) 463 206 669 All-in sustaining cost 24,058 18,149 53,502 Payable gold in concentrates soldoz37,725 15,503 53,228 Cost of sales per ounce of gold sold(7)$/oz1,069 1,742 1,265 Cash cost per ounce of gold sold(7)$/oz534 938 652 All-in sustaining cost per ounce of gold sold(7)$/oz638 1,171 1,005 Article content(1) Included in cost of sales were share-based compensation expenses of $0.9 million (2024 – $0.7 million) in the third quarter of 2025.(2) Represent revenue deductions for treatment charges, refining charges, penalties, freight and final settlements to adjust for any differences relative to the provisional invoice.(3) Represent copper and silver revenue.(4) Included in cost of sales and finance cost in the condensed interim consolidated statements of earnings (loss).(5) Represent an allocated portion of DPM’s general and administrative expenses, including share-based compensation expenses of $16.7 million (2024 – $5.4 million) for the third quarter of 2025, based on Chelopech’s and Ada Tepe’s proportion of total revenue, excluding revenue from Vareš, while including revenue from discontinued operations in 2024. Allocated general and administrative expenses, including corporate social responsibility expenses and excluding depreciation and amortization, are reflected in consolidated all-in sustaining cost per ounce of gold sold and are not reflected in the cost measures for Chelopech and Ada Tepe.(6) Included in cash used in investing activities and financing activities, respectively, in the condensed interim consolidated statements of cash flows.(7) Represents cost of sales, mine cash cost of sales and all-in sustaining cost, respectively, divided by payable gold in concentrates sold.Article content$ thousands, unless otherwise indicated For the nine months ended September 30, 2025 Chelopech Ada Tepe Consolidated,excluding Vareš Cost of sales(1) 122,842 83,858 206,700 Add/(deduct): Depreciation and amortization (25,393)(43,452)(68,845)Treatment charges, transportation and other related selling costs(2) 46,623 394 47,017 By-product credits(3) (81,130)(799)(81,929)Mine cash cost of sales 62,942 40,001 102,943 Rehabilitation related accretion and depreciation expenses(4) 41 1,798 1,839 Allocated general and administrative expenses(5) – – 49,900 Cash outlays for sustaining capital expenditures(6) 9,887 9,985 19,872 Cash outlays for leases(6) 1,664 576 2,240 All-in sustaining cost 74,534 52,360 176,794 Payable gold in concentrates soldoz110,382 45,196 155,578 Cost of sales per ounce of gold sold(7)$/oz1,113 1,855 1,329 Cash cost per ounce of gold sold(7)$/oz570 885 662 All-in sustaining cost per ounce of gold sold(7)$/oz675 1,159 1,136 Article content$ thousands, unless otherwise indicated For the nine months ended September 30, 2024 Chelopech Ada Tepe Consolidated,excluding Vareš Cost of sales(1) 114,054 80,722 194,776 Add/(deduct): Depreciation and amortization (23,742) (40,933) (64,675)Treatment charges, transportation and other related selling costs(2) 49,836 1,582 51,418 By-product credits(3) (81,323) (779) (82,102)Mine cash cost of sales 58,825 40,592 99,417 Rehabilitation related accretion expenses(4) 159 970 1,129 Allocated general and administrative expenses(5) – – 27,059 Cash outlays for sustaining capital expenditures(6) 9,459 7,070 16,529 Cash outlays for leases(6) 803 544 1,347 All-in sustaining cost 69,246 49,176 145,481 Payable gold in concentrates soldoz 105,142 64,121 169,263 Cost of sales per ounce of gold sold(7)$/oz 1,085 1,259 1,151 Cash cost per ounce of gold sold(7)$/oz 559 633 587 All-in sustaining cost per ounce of gold sold(7)$/oz 659 767 859 Article content(1) Included in cost of sales were share-based compensation expenses of $3.5 million (2024 – $1.7 million) in the first nine months of 2025.(2) Represents revenue deductions for treatment charges, refining charges, penalties, freight and final settlements to adjust for any differences relative to the provisional invoice.(3) Represents copper and silver revenue.(4) Included in cost of sales and finance cost in the condensed interim consolidated statements of earnings (loss).(5) Represents an allocated portion of DPM’s general and administrative expenses, including share-based compensation expenses of $31.3 million (2024 – $11.0 million) in the first nine months of 2025, based on Chelopech and Ada Tepe’s proportion of total revenue, excluding revenue from Vareš, while including revenue from discontinued operations in 2024. Allocated general and administrative expenses are reflected in consolidated all-in sustaining cost per ounce of gold sold and are not reflected in the cost measures for Chelopech and Ada Tepe.(6) Included in cash used in investing activities and financing activities, respectively, in the condensed interim consolidated statements of cash flows.(7) Represents cost of sales, mine cash cost of sales and all-in sustaining cost, respectively, divided by payable gold in concentrates sold.Article contentAdjusted net earnings (loss) and adjusted basic earnings (loss) per share Article contentAdjusted net earnings (loss) is a non-GAAP financial measure and adjusted basic earnings (loss) per share is a non-GAAP ratio used by management and investors to measure the underlying operating performance of the Company. Presenting these measures from period to period helps management and investors evaluate earnings trends more readily in comparison with results from prior periods.Article contentAdjusted net earnings (loss) are defined as net earnings, adjusted to exclude specific items that are significant, but not reflective of the underlying operations of the Company, including:Article contentimpairment charges or reversals thereof;unrealized and realized gains or losses related to investments carried at fair value;significant tax adjustments not related to current period earnings; andnon-recurring or unusual income or expenses that are either not related to the Company’s operating segments or unlikely to occur on a regular basis.Article contentThe following table provides a reconciliation of adjusted net earnings to net earnings from continuing operations:Article content$ thousands, except per share amounts Three Months Nine MonthsEnded September 30, 20252024 20252024 Net earnings 95,98546,203 211,888156,478 Add/(deduct): Adriatic acquisition related costs, net of income taxes of $nil 10,276– 15,406– Non-cash fair value adjustment on inventories, net of income tax recoveries of $2,547(1) 22,923– 22,923– 2025 Bulgarian levy, net of income tax recoveries of $2,438(2) –– 21,938– Net termination fee received from Osino, net of income taxes of $nil –– –(6,901)Adjusted net earnings 129,18446,203 272,155149,577 Basic earnings per share$/sh0.540.26 1.230.87 Adjusted basic earnings per share$/sh0.730.26 1.570.83 Article content(1) Represents a non-cash fair value adjustment on inventories recognized in cost of sales with the sale of inventories at Vareš, following the acquisition of Adriatic.(2) Represents a one-time levy to the 2025 Bulgarian state budget in respect of both the Chelopech and Ada Tepe mines.Article contentAdjusted EBITDAArticle contentAdjusted EBITDA is a non-GAAP financial measure used by management and investors to measure the underlying operating performance of the Company’s operating segments. Presenting these measures from period to period helps management and investors evaluate earnings trends more readily in comparison with results from prior periods. In addition, the Human Capital and Compensation Committee of the Board of Directors uses adjusted EBITDA, together with other measures, to set incentive compensation goals and assess performance.Article contentAdjusted EBITDA excludes the following from earnings before income taxes:Article contentdepreciation and amortization;interest income;finance cost;impairment charges or reversals thereof;unrealized and realized gains or losses related to investments carried at fair value; andnon-recurring or unusual income or expenses that are either not related to the Company’s operating segments or unlikely to occur on a regular basis.Article contentThe following table provides a reconciliation of adjusted EBITDA to earnings (loss) before income taxes from continuing operations:Article content$ thousandsThree Months Nine MonthsEnded September 30,2025 2024 2025 2024 Earnings before income taxes108,391 55,271 238,947 181,770 Add/(deduct): Depreciation and amortization28,181 21,636 72,044 66,580 Finance costs1,805 821 3,617 2,223 Interest income(8,493)(9,223) (24,910)(27,565)Non-cash fair value adjustment on inventories(1)25,470 – 25,470 – Adriatic acquisition related costs10,276 – 15,406 – 2025 Bulgarian levy(2)– – 24,376 – Net termination fee received from Osino– – – (6,901)Adjusted EBITDA165,630 68,505 354,950 216,107 Article content(1) Represents a non-cash fair value adjustment on inventories recognized in cost of sales with the sale of inventories at Vareš, following the acquisition of Adriatic.(2) Represents a one-time levy to the 2025 Bulgarian state budget in respect of both the Chelopech and Ada Tepe mines.Article contentCash provided from operating activities, before changes in working capitalArticle contentCash provided from operating activities, before changes in working capital, is a non-GAAP financial measure defined as cash provided from operating activities excluding changes in working capital as set out in the Company’s consolidated statements of cash flows. This measure is used by the Company and investors to measure the cash flow generated by the Company’s operating segments prior to any changes in working capital, which at times can distort performance.Article contentFree cash flowArticle contentFree cash flow is a non-GAAP financial measure defined as cash provided from operating activities, before changes in working capital which includes changes in share-based compensation liabilities, less cash outlays for sustaining capital expenditures, mandatory principal repayments and interest payments related to debt and leases. Free cash flow excludes non-recurring or unusual income or expenses that are not related to the Company’s operating segments. This measure is used by the Company and investors to measure the cash flow available to fund growth related initiatives and capital expenditures, dividends and share repurchases.Article contentThe following table provides a reconciliation of cash provided from operating activities, before changes in working capital and free cash flow to cash provided from operating activities of continuing operations:Article content$ thousandsThree Months Nine MonthsEnded September 30,2025 2024 2025 2024 Cash provided from operating activities184,576 52,489 339,043 214,082 Excluding: Changes in working capital(1)(29,061)16,165 (17,994)23,387 Cash provided from operating activities, before changes in working capital(2)155,515 68,654 321,049 237,469 Adriatic acquisition related costs10,276 – 15,406 – 2025 Bulgarian levy(3)(6,094)– 12,188 – Cash outlays for sustaining capital expenditures(4)(8,695)(7,432) (20,474)(18,743)Principal repayments related to leases(1,752)(1,508) (4,558)(3,633)Interest payments(4)(1,483)(492) (2,176)(1,191)Other non-cash items– 11,700 – (500)Free cash flow147,767 70,922 321,435 213,402 Article content(1) Excludes a change of $nil (2024 – an unfavourable change of $117.4 million) and a favourable change of $167.9 million (2024 – an unfavourable change of $100.8 million) in working capital from discontinued operations, respectively, during the third quarter and first nine months of 2025.(2) Excludes cash used in operating activities of discontinued operations, before changes in working capital, of $17.8 million and $9.7 million, respectively, during the third quarter and first nine months of 2024.(3) Represents an accrual of a one-time levy to the 2025 Bulgarian state budget in respect of both the Chelopech and Ada Tepe mines. During the third quarter of 2025, $6.1 million was paid in cash and the remaining accrual was $12.2 million as at September 30, 2025.(4) Included in cash used in investing and financing activities, respectively, in the condensed interim consolidated statements of cash flows.Article contentAverage realized metal pricesArticle contentAverage realized gold and copper prices are non-GAAP ratios used by management and investors to highlight the price actually realized by the Company relative to the average market price, which can differ due to the timing of sales, hedging and other factors.Article contentAverage realized gold and copper prices represent the average per unit price recognized in the Company’s consolidated statements of earnings (loss) prior to any deductions for treatment charges, refining charges, penalties, freight and final settlements to adjust for any differences relative to the provisional invoice.Article contentThe following table provides a reconciliation of the Company’s average realized gold and copper prices to its revenue, excluding Vareš:Article content$ thousands, unless otherwise stated Three Months Nine MonthsEnded September 30, 2025 2024 2025 2024 Total revenue 267,413 147,262 598,047 427,891 Add/(deduct): Vareš revenue (41,819) – (41,819) – Treatment charges and other deductions(1) 18,262 17,097 47,017 51,418 Silver revenue (2,734) (1,246) (6,135) (3,856)Revenue from gold and copper 241,122 163,113 597,110 475,453 Revenue from gold 210,486 135,634 521,315 397,191 Payable gold in concentrates soldoz 57,912 53,228 155,578 169,263 Average realized gold price per ounce$/oz 3,635 2,548 3,351 2,347 Revenue from copper 30,636 27,479 75,795 78,262 Payable copper in concentrate soldKlbs 6,820 6,484 17,187 18,410 Average realized copper price per pound$/lb 4.49 4.24 4.41 4.25 Article content(1) Represent revenue deductions for treatment charges, refining charges, penalties, freight and final settlements to adjust for any differences relative to the provisional invoice.Article contentArticle contentArticle contentArticle contentArticle contentArticle content

Nov 13, 2025

Technology

Peyto Reports Third Quarter Results and Preliminary 2026 Capital Program

1This press release contains certain non-GAAP and other financial measures to analyze financial performance, financial position, and cash flow including, but not limited to “operating margin”, “profit margin”, “return on capital”, “return on equity”, “netback”, “funds from operations”, “free funds flow”, “total cash costs”, and “net debt”. These non-GAAP and other financial measures do not have any standardized meaning prescribed under IFRS® Accounting Standards and therefore may not be comparable to similar measures presented by other entities. The non-GAAP and other financial measures should not be considered to be more meaningful than GAAP measures which are determined in accordance with IFRS, such as earnings, cash flow from operating activities, and cash flow used in investing activities, as indicators of Peyto’s performance. See “Non-GAAP and Other Financial Measures” included at the end of this press release and in Peyto’s most recently filed MD&A for an explanation of these financial measures and reconciliation to the most directly comparable financial measure under IFRS.2 Funds from operations is a non-GAAP financial measure. See “non-GAAP and Other Financial Measures” in this news release and in the Q3 2025 MD&A.3 Free funds flow is a non-GAAP financial measure. See “non-GAAP and Other Financial Measures” in this news release and in the Q3 2025 MD&A.4Cash costs is a non-GAAP financial measure. See “non-GAAP and Other Financial Measures” in this news release.5Total capital expenditures is a non-GAAP financial measure. See “non-GAAP and Other Financial Measures” in this news release and in the Q3 2025 MD&A.6Net debt a non-GAAP financial measure. See “non-GAAP and Other Financial Measures” in this news release and in the Q3 2025 MD&A.7Operating Margin is a non-GAAP financial ratio. See “non-GAAP and Other Financial Measures” in this news release.8Profit Margin is a non-GAAP financial ratio. See “non-GAAP and Other Financial Measures” in this news release.9Return on capital employed and return on equity are non-GAAP financial ratios. See “non-GAAP and Other Financial Measures” in this news release.10Total Cash costs is a non-GAAP financial ratio. See “non-GAAP and Other Financial Measures” in this news release.11 Cash netback is a non-GAAP financial ratio. See “non-GAAP and Other Financial Measures” in this news release and in the Q32025 MD&A.

Nov 13, 2025

Technology

Enthusiast Gaming Reports Q3 2025 Financial Results

U.GG increased advertising revenues by 25.1% in Q3 2025 compared to Q2 2025. This growth was driven primarily by a 10.9% improvement in average session duration quarter-over-quarter reflecting enhanced user engagement on the platform, seasonal uplifts in CPMs, and additional ad tech optimizations deployed within the quarter. The platform also saw the launch of U.GG’s ‘mono-app’, combining its League of Legends and Valorant applications under a single desktop application while allowing for the integration of new titles on a modular basis. These advancements are expected to significantly increase the speed with which U.GG can deploy applications for new titles. Icy Veins saw considerable growth in Q3 2025, increasing users by 31.8% and total time with gamers by 27.9% relative to Q2 2025, all while expanding its operating margin and making significant progress in its modernization initiatives planned for Q1 2026 ahead of the major expansions announced for its flagship titles, World of Warcraft and Diablo IV. Q3 2025 also marked a period of growth for Icy Veins’ nascent news offering, the success of which has warranted increased investment in the development of a net-new product for the Company, planned for release in H1 2026. TheSimsResource continued to evolve its first-to-market LookBuilder tool, which launched in June, providing users with a browser-based, 3D-rendered, real-time outfit preview engine that enables players to build and customize complete outfits and see them visualized on a character instantly. Feature enhancements completed in Q3 include the addition of poses, multi-file download to allow for one-click outfit saving, improved rendering to better replicate how custom content appears in-game, and the launch of the My Current Look tab, with improved display and navigation controls. LookBuilder is available for both free and paid users and is intended to drive deeper engagement across the platform. Addicting Games launched significant updates to its iconic casual gaming platform in Q3, providing users with a more modern design, streamlined navigation, and optimized performance. Further enhancements are underway to improve the mobile experience and capitalize on clear synergies with the Company’s PocketGamer brand, which represents one of the world’s leading mobile gaming destinations on the web and the pre-eminent B2B mobile gaming conference and event series.

Nov 13, 2025

Business

Omni-Lite Industries Announces Results of Annual General Meeting

Except for statements of historical fact, this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intent”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking information in this press release includes, but is not limited to, the expectations and future performance of the Company and the timing, date and location of the Meeting. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: general economic conditions in Canada, the United States and globally; industry conditions, governmental regulation, including environmental consents and approvals, if and when required; stock market volatility; competition for, among other things, capital, skilled personnel and supplies; changes in tax laws; and the other risk factors disclosed under our profile on SEDAR at www.sedar.com. Readers are cautioned that this list of risk factors should not be construed as exhaustive.

Nov 13, 2025

Technology

Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results after Dosing with EP-104GI

This news release includes forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “is expected”, “expects”, “suggests”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes”, “potential” or variations (including negative and grammatical variations) of such words and phrases, or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements in this news release include statements regarding the Company’s expected timing of reporting additional data from the RESOLVE trial; the Company’s product candidates, including their expected benefits to patients with respect to safety, tolerability, efficacy and duration and potential uses in therapeutic areas beyond pain and inflammatory gastrointestinal disease; the expectations around proceeding to clinical trials for the Company’s product candidates; the results gathered from studies and trials of Eupraxia’s product candidates; the potential for the Company’s technology to impact the drug delivery process; potential market opportunity for the Company’s product candidates; and potential pipeline indications. Such statements and information are based on the current expectations of Eupraxia’s management, and are based on assumptions, including but not limited to: future research and development plans for the Company proceeding substantially as currently envisioned; industry growth trends, including with respect to projected and actual industry sales; the Company’s ability to obtain positive results from the Company’s research and development activities, including clinical trials; and the Company’s ability to protect patents and proprietary rights. Although Eupraxia’s management believes that the assumptions underlying these statements and information are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this news release may not occur by certain dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting Eupraxia, including, but not limited to: risks and uncertainties related to the Company’s limited operating history; the Company’s novel technology with uncertain market acceptance; if the Company breaches any of the agreements under which it licenses rights to its product candidates or technology from third parties, the Company could lose license rights that are important to its business; the Company’s current license agreement may not provide an adequate remedy for its breach by the licensor; the Company’s technology may not be successful for its intended use; the Company’s future technology will require regulatory approval, which is costly and the Company may not be able to obtain it; the Company may fail to obtain regulatory approvals or only obtain approvals for limited uses or indications; the Company’s clinical trials may fail to demonstrate adequately the safety and efficacy of its product candidates at any stage of clinical development; the Company may be required to suspend or discontinue clinical trials due to side effects or other safety risks; the Company completely relies on third parties to provide supplies and inputs required for its product candidates and services; the potential impact of tariffs on the cost of the Company’s active pharmaceutical ingredients and clinical supplies of EP-104IAR and EP-104GI; the Company relies on external contract research organizations to provide clinical and non-clinical research services; the Company may not be able to successfully execute its business strategy; the Company will require additional financing, which may not be available; any therapeutics the Company develops will be subject to extensive, lengthy and uncertain regulatory requirements, which could adversely affect the Company’s ability to obtain regulatory approval in a timely manner, or at all; the impact of health pandemics or epidemics on the Company’s operations; the Company’s restatement of its consolidated financial statements, which may lead to additional risks and uncertainties, including loss of investor confidence and negative impacts on the Company’s common share price; and other risks and uncertainties described in more detail in Eupraxia’s public filings on SEDAR+ (sedarplus.ca) and EDGAR (sec.gov). Although Eupraxia has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements and information, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement or information can be guaranteed. Except as required by applicable securities laws, forward-looking statements and information speak only as of the date on which they are made and Eupraxia undertakes no obligation to publicly update or revise any forward-looking statement or information, whether as a result of new information, future events or otherwise.

Nov 13, 2025

Business

Aptose Reports Third Quarter 2025 Results

This press release contains forward-looking statements within the meaning of Canadian and U.S. securities laws, including, but not limited to, statements regarding the Company’s clinical development plans, the clinical potential, anti-cancer activity, therapeutic potential and applications and safety profile of tuspetinib, clinical trials, upcoming milestones and presentation of additional data, financing and cost reduction efforts, expectations regarding capital available to the Company to fund planned Company operations, the Company’s cash runway, and statements relating to the Company’s plans, objectives, expectations and intentions and other statements including words such as “continue”, “expect”, “intend”, “will”, “hope” “should”, “would”, “may”, “potential” and other similar expressions. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by us, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others: our ability to obtain the capital required for research and operations; the inherent risks in early stage drug development including demonstrating efficacy; development time/cost and the regulatory approval process; the progress of our clinical trials; our ability to find and enter into agreements with potential partners; our ability to attract and retain key personnel; changing market and economic conditions; unexpected manufacturing defects, the evolving regulatory and political landscape and the funding of government programs and other risks detailed from time-to-time in our ongoing current reports, quarterly filings, annual information forms, annual reports and Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled “Risk Factors” in our filings with Canadian securities regulators and the United States Securities and Exchange Commission underlying those forward- looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and we do not intend, and do not assume any obligation, to update these forward-looking statements, except as required by law. We cannot assure you that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Investors are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

Nov 13, 2025

Business

Stantec reports strong third quarter 2025 results, delivering over 17% growth in adjusted earnings per share

Net revenue increased 11.8% or $180.6 million, to $1.7 billion, driven by 5.6% organic growth and 5.2% acquisition growth. Stantec achieved organic growth in all of its regional and business operating units, most notably in Water with double-digit organic growth. Project margin increased 12.1% or $99.8 million, to $927.9 million. As a percentage of net revenue, project margin increased 10 basis points to 54.4%, remaining in line with expectations. Adjusted EBITDA increased 17.8% or $48.8 million, to $323.4 million. Adjusted EBITDA margin was 19.0%, an increase of 100 basis points compared to Q3 2024. The increase in margin primarily reflects lower administrative and marketing expenses as a percentage of net revenue, mainly due to Stantec’s disciplined management of operations and higher utilization. Net income increased 45.3% or $46.8 million, to $150.0 million, and diluted EPS increased 46.7%, or $0.42, to $1.32, mainly due to increases in project margin and, as a percentage of revenue, lower administrative and marketing expenses partly offset by higher income tax expense. As well, Q3 2024 included a non-cash impairment charge of $13.7 million from our real estate optimization strategy. Adjusted net income grew 17.7% or $26.2 million, to $174.1 million, achieving 10.2% of net revenue—an increase of 50 basis points. Adjusted EPS increased 17.7% or $0.23, to $1.53. Contract backlog increased to $8.4 billion at September 30, 2025, achieving 14.9% overall growth year over year, which includes 6.8% acquisition growth and 5.6% organic growth. Organic growth was achieved in all of Stantec’s regional operating units. Contract backlog represents approximately 13 months of work. Operating cash flows increased $137.0 million or 76.6%, with cash inflows of $315.9 million, reflecting strong revenue growth, operational performance, and collection efforts. DSO was 73 days, a decrease of 4 days from December 31, 2024. Net debt to adjusted EBITDA (on a trailing twelve-month basis) at September 30, 2025 was 1.5x, reflecting the funding of the recent acquisition of Page, and remained within our internal target range of 1.0x to 2.0x. On July 31, 2025, we acquired Page, a 1,400-person architecture and engineering firm headquartered in Washington, DC that strategically complements Stantec’s Buildings business and serves the advanced manufacturing, healthcare, mission critical, academic, civic, aviation, science and technology, and commercial markets. On November 13, 2025, Stantec’s Board of Directors declared a dividend of $0.225 per share, payable on January 15, 2026, to shareholders of record on December 31, 2025.

Nov 13, 2025

Business

RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: the resolution of the litigation that RAMM is pursuing and defending; financial risk in connection with the litigation; the amount accrued in the Company’s financial statements in respect of the litigation; future growth potential of the Company; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Uruguayan, Latin American, European and international medical and recreational cannabis markets and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in Uruguay or internationally; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

Nov 13, 2025

Business

IKO Expands Performance Shingle Collection with the Launch of Olde Style Weatherwood Color

This impact rating is solely for the purpose of enabling residential property owners to obtain a reduction in their residential insurance premium, if available. It is not to be construed as any type of express or implied warranty or guarantee of the impact performance of this shingle by the manufacturer, supplier or installer. For further detail concerning the FM 4473 standards, visit the FM Approvals website. This is not a guarantee of impact resistance against hail. Damage from hail is not covered under the limited warranty.About IKOIKO is a worldwide leader in the roofing, waterproofing and insulation industry for residential and commercial markets. A vertically integrated company, IKO operates more than 35 manufacturing plants throughout North America and Europe. IKO is a family-owned business established in 1951.

Nov 12, 2025

Business

StorageVault Announces $50 Million Bought Deal Offering of 5.60% Senior Unsecured Hybrid Debentures

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. In particular, this news release contains forward-looking information regarding: the Offering, including statements regarding the filing of a preliminary short form prospectus, the timing and expected completion of the Offering, receipt of all regulatory and TSX approvals and the use of net proceeds of the Offering‎. There can be no assurance that such forward-looking information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such forward-looking information. This forward-looking information reflects StorageVault’s current beliefs, estimates, forecasts and projections and is based on information currently available to StorageVault and on assumptions StorageVault believes are reasonable. These assumptions include, but are not limited to, assumptions regarding: all conditions to completion of the Offering being satisfied or waived, including obtaining TSX for the Offering and the listing of the Debentures; ‎present and future business strategies of StorageVault; the environment in which StorageVault ‎will operate in the future; and ‎expected revenues, expansion plans and StorageVault’s ability to achieve its goals. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of StorageVault to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delay or failure to receive third party or regulatory approvals; the actual results of StorageVault’s future operations; competition; changes in legislation, including environmental legislation, affecting StorageVault; the timing and availability of external financing on acceptable terms; conclusions of economic evaluations and appraisals; lack of qualified, skilled labour or loss of key individuals; and the impact that the imposition of trade tariffs, particularly from the United States, may have on the global economy, and the economy in Canada in particular. A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in StorageVault’s disclosure documents on the SEDAR+ website at www.sedarplus.ca. Although StorageVault has attempted to identify important risks and factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of StorageVault as of the date of this news release and, accordingly, is subject to change after such date. However, StorageVault expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Nov 12, 2025

Technology

Ghosts of Soldiers Past to Walk the Streets of Toronto

Among the walking ghosts is Private Fred Lee, an original Rocky Mountain Ranger and machine gunner of the 172nd Battalion. Born in Kamloops BC, Lee was one of just three known soldiers of Chinese descent. He disappeared without a trace at the Battle of Hill 70 and has no known grave. His name is carved into the stone walls of the Vimy Memorial, along with 11,285 others. Like all the ghosts appearing on the Toronto streets, Private Fred Lee cannot talk or engage with passers-by, but he will show you his data card that tells his story for all to know. Fred Lee was the subject of two documentaries, Finding Fred Lee 1.0 and One of OURS – The Life of Private Fred Lee, both produced and directed by Jack Gin.

Nov 6, 2025

Technology

Humanoid Global Unaware of Material Change

Humanoid Global Holdings Corp. (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF) (“Humanoid Global” or the “Company”) is a publicly traded investment issuer building a portfolio of pioneering companies in the growing humanoid robotics and embodied AI sector, investing in and accelerating their growth. It serves as a global investment platform providing liquidity and access to an actively managed portfolio spanning the value chain of this emerging ecosystem, including advanced software, hardware, and enabling technologies. Led by a team with a proven track record of scaling transformative technologies globally, the Company takes a long-term, partnership-oriented approach. It provides capital and strategic consultation on go-to-market strategies, regulatory pathways, and transaction advisory, while facilitating introductions to customers, suppliers, and strategic partners.

Nov 3, 2025

Technology

D&H Canada Expands Portfolio with Addition of Dell Solutions and Services

About D&H CanadaD&H Canada supports resellers and MSP partners in the corporate, SMB, mid-market, enterprise and government markets with endpoints and advanced technologies, as well as differentiated services. For generations, D&H’s employee co-owners have prioritized people and partnerships, adapting alongside the market to deliver innovative strategies, consultative support, and end-to-end technology solutions. Through customized services and a “Built for Growth” mindset, D&H helps partners capitalize on market opportunities with white glove support and comprehensive enablement resources. D&H’s Canadian headquarters is in Mississauga, ONT, with distribution hubs in Toronto and Vancouver. The company’s US headquarters is in Harrisburg, PA, with a center of excellence in Tampa, FL. Engage with D&H Canada at www.dandh.ca, and follow us on LinkedIn, Facebook, and X to stay connected.

Nov 3, 2025

Business

China’s Xizang: Ali Prefecture’s cultural tourism industry goes viral, painting a happy picture of cultural and tourism integration

Ali Prefecture’s Bureau of Culture and Tourism LHASA, China, Oct. 27, 2025 (GLOBE NEWSWIRE) — On October 22, the Ali Prefecture’s Bureau of Culture and Tourism participated in the 2025 Northwestern Xizang Culture and Tourism Promotion Alliance Conference in Chengdu. The event laid a foundation for building Ali Prefecture into a world-class travel destination and […]

Oct 28, 2025

Business

Enabled Talent Launches from Brampton to Tap Into the World’s Largest Untapped Workforce

BRAMPTON, Ontario, Oct. 26, 2025 (GLOBE NEWSWIRE) — With over 600 million people with disabilities globally facing unemployment rates between 70–90%, Enabled Talent officially launched its full-scale inclusive employment platform from Brampton’s Innovation District, expanding internationally with a regional rollout in Africa. Founded by a partially blind entrepreneur and powered by the lived experience of its […]

Oct 26, 2025

Business

New Global Coalition Launches to Address the Hidden Threat of RSV in Adults

VIENNA, Austria, Oct. 26, 2025 (GLOBE NEWSWIRE) — A new global coalition, the RSV Alliance, has been launched to raise awareness about the risks of respiratory syncytial virus (RSV) infections, with a focus on aging populations and individuals with underlying health conditions. With core members including leading advocacy organizations the International Federation on Ageing (IFA) […]

Oct 26, 2025

AI & Technology Virtual Investor Conference Agenda Announced for October 28th

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) — Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for the AI & Technology Virtual Investor Conference to be held on October 28th. Individual investors, institutional investors, advisors, and analysts are invited to attend. […]

Oct 23, 2025

UFC® and Smith+Nephew announce multi-year extension of partnership

Smith+Nephew to continue as UFC’s Preferred Sports Medicine Technology Partner Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world’s premier mixed martial arts organization, have announced a multi-year extension of their landmark worldwide marketing partnership forged in 2024.  Under the renewal, Smith+Nephew will continue as UFC’s Preferred Sports Medicine Technology Partner, a […]

Oct 22, 2025

Business

Saudia Unveils SV Lifestyle Brand at Riyadh Fashion Week

Premium line inspired by Saudia’s legacy and global spirit makes debut under the theme “Live to Fly” RIYADH, Saudi Arabia, Oct. 22, 2025 (GLOBE NEWSWIRE) — Saudia, the national flag carrier of the Kingdom of Saudi Arabia, unveiled its new premium lifestyle brand, SV, during an exclusive runway show held at The Roof at Al […]

Oct 22, 2025